OverviewSuggest Edit
AbbVie is a pharmaceutical company that discovers, develops, and markets oncology, virology, metabolics and hormones, endocrinology, and other products. Its products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions.
| Type | Public | |
| Founded | 2013 | |
| HQ | Lake Bluff, US | Map |
| Website | abbvie.com | |
| Employee Ratings | More |
Recent NewsAll News
- Global Facial Aesthetics Market (2020 to 2024) - Featuring AbbVie, Adoderm & Alma Lasers Among Others
- Global DNA Damage Response Drugs Market Analysis and Competitor Profiles 2020, Featuring AbbVie Inc., AstraZeneca plc, Bayer AG, Pfizer Inc. and More
- Daily Dividend Report: AbbVie, Bristol Myers Squibb, Colgate-Palmolive, American Tower, Cerner
- Drugmaker AbbVie pressures reluctant employees to return to work, raising safety questions
Key People/Management at AbbVie
Richard A. Gonzalez
Chairman of the Board and Chief Executive Officer
Michael E. Severino
Vice Chairman and President
Laura J. Schumacher
Vice Chairman, External Affairs and Chief Legal Officer
Carlos Alban
Vice Chairman, Chief Commercial Officer
Rae L. Livingston
Chief Equality Officer
Henry O. Gosebruch
Executive Vice President, Chief Strategy Officer
AbbVie Office Locations
AbbVie has offices in Lake Bluff, Cambridge, Mettawa, North Chicago and in 60 other locations
Lake Bluff, US (HQ)
1 Waukegan Rd
Cambridge, US
200 Sidney St
Mettawa, US
26525 Riverwoods Blvd
North Chicago, US
1401 Sheridan Rd
Redwood City, US
1500 Seaport Blvd
South San Francisco, US
450 E Jamie Ct
AbbVie Financials and Metrics
AbbVie Revenue
AbbVie's revenue was reported to be $33.27 b in FY, 2019 which is a 1.6% increase from the previous period.
| USD | |
|---|---|
Revenue (Q2, 2020) | 10.4b |
Gross profit (Q2, 2020) | 6.7b |
Gross profit margin (Q2, 2020), % | 64.4% |
Net income (Q2, 2020) | (739.0m) |
EBIT (Q2, 2020) | 752.0m |
Market capitalization (23-Sept-2020) | 153.8b |
Closing stock price (23-Sept-2020) | 87.1 |
Cash (30-Jun-2020) | 6.0b |
EV | 235.2b |
AbbVie's current market capitalization is $153.8 b.
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.5b | 6.9b | 7.0b | 7.9b | 8.3b | 8.2b | 7.8b | 8.3b | 8.5b | 8.6b | 10.4b |
Cost of goods sold | 1.6b | 1.5b | 1.6b | 1.9b | 1.9b | 1.8b | 1.7b | 1.8b | 1.9b | 1.9b | 3.7b |
Gross profit | 4.9b | 5.4b | 5.4b | 6.0b | 6.3b | 6.4b | 6.1b | 6.4b | 6.6b | 6.7b | 6.7b |
Gross profit Margin, % | 75% | 78% | 77% | 76% | 77% | 78% | 78% | 78% | 77% | 77% | 64% |
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 4.7b | 6.1b | 8.4b | 9.0b | 3.5b | 8.0b | 4.9b | 5.2b | 10.6b | 41.1b | 6.0b |
Accounts Receivable | 4.7b | 4.9b | 4.9b | 5.8b | 5.8b | 5.8b | 5.7b | 5.5b | 5.5b | 6.4b | 8.4b |
Prepaid Expenses | 3.2b | 3.3b | 2.7b | 3.4b | 2.7b | 2.1b | 1.8b | 2.3b | 2.1b | 2.4b | 2.8b |
Inventories | 1.4b | 1.6b | 1.8b | 1.7b | 1.6b | 1.8b | 1.7b | 1.9b | 1.9b | 1.8b | 4.1b |
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 1.7b | 3.6b | 5.3b | 2.8b | 4.8b | 7.5b | 2.5b | 3.2b | 5.1b | 3.0b | 2.3b |
Depreciation and Amortization | 374.0m | 753.0m | 1.1b | 445.0m | 888.0m | 1.3b | 503.0m | 1.0b | 1.5b | 559.0m | 264.0m |
Inventories | 71.0m | 1.0m | (119.0m) | (71.0m) | (191.0m) | (367.0m) | (128.0m) | (288.0m) | (401.0m) | (107.0m) | (304.0m) |
Accounts Payable | (266.0m) | (530.0m) | 444.0m | 191.0m | 12.0m | 881.0m | 94.0m | (1.3b) | (582.0m) | 1.1b | 466.0m |
| USD | FY, 2016 |
|---|---|
Revenue/Employee | 915.6k |
Debt/Equity | 7.9 x |
Debt/Assets | 0.6 x |
Financial Leverage | 14.3 x |
AbbVie Operating Metrics
AbbVie's Patients was reported to be 30 m in FY, 2018.
AbbVie Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Mavupharma | July 15, 2019 | |
| Allergan | June 25, 2019 | $80 b |
| Stem CentRx | April 28, 2016 | $5.80 b |
| Pharmacyclics Inc | March 04, 2015 | |
| ImmuVen | January 01, 2014 | |
| AbbVie AB | ||
| AbbVie AG | ||
| AbbVie AS | ||
| AbbVie A/S | ||
| AbbVie Australasia Holdings Limited |
AbbVie Cybersecurity Score
AbbVie Revenue Breakdown
AbbVie revenue breakdown by geographic segment: 28.1% from International and 71.9% from United States
AbbVie Online and Social Media Presence
65.45k Twitter followers
AbbVie has 65.45k Twitter Followers. The number of followers has increased 1.1% month over month and increased 5.1% quarter over quarter
AbbVie's Trends
Twitter Engagement Stats for @abbvie
6.4k
Tweets
498
Following
65.4k
Followers
53
Tweets last 30 days
7
Avg. likes per Tweet
90.6%
Tweets with engagement
AbbVie News and Updates
September 23, 2020
Global Facial Aesthetics Market (2020 to 2024) - Featuring AbbVie, Adoderm & Alma Lasers Among Others
Dublin, Sept. 23, 2020 (GLOBE NEWSWIRE) -- The "Global Facial Aesthetics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The facial aesthetics market is poised to grow by USD 2.57 bn during 2020-2024 progressing at a CAGR of 7% during the forecast period. The reports…
September 15, 2020
Global DNA Damage Response Drugs Market Analysis and Competitor Profiles 2020, Featuring AbbVie Inc., AstraZeneca plc, Bayer AG, Pfizer Inc. and More
DUBLIN, Sept. 15, 2020 /PRNewswire/ -- The "Global DNA Damage Response Drugs Market: Focus on Commercialized Drugs, Potential Pipeline Drugs, Application, Country Data (13 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets....
September 11, 2020
Daily Dividend Report: AbbVie, Bristol Myers Squibb, Colgate-Palmolive, American Tower, Cerner
Daily Dividend Report: AbbVie, Bristol Myers Squibb, Colgate-Palmolive, American Tower, Cerner
September 11, 2020
Drugmaker AbbVie pressures reluctant employees to return to work, raising safety questions
Even if employees have demonstrated an ability to do their jobs from home, the company expects them to report to the office to foster creativity and innovation under its phased-in return-to-work plan.
September 04, 2020
I-Mab's stock soars after AbbVie collaboration, which could be worth nearly $2 billion
Shares of I-Mab soared 17% in premarket trading Friday toward a record high, after the China-based biotechnology company announced a collaboration agreement with AbbVie Inc. to develop and commercialize I-Mab's lemzoparlimab for the treatment of multiple cancers. AbbVie's stock edged up 0.1% ahead…
September 04, 2020
AbbVie Inks $2.9 Billion Cancer Deal With China’s I-Mab
AbbVie Inks $2.9 Billion Cancer Deal With China’s I-Mab
AbbVie Frequently Asked Questions
When was AbbVie founded?
AbbVie was founded in 2013.
Who are AbbVie key executives?
AbbVie's key executives are Richard A. Gonzalez, Michael E. Severino and Laura J. Schumacher.
How many employees does AbbVie have?
AbbVie has 30,000 employees.
What is AbbVie revenue?
Latest AbbVie annual revenue is $33.3 b.
What is AbbVie revenue per employee?
Latest AbbVie revenue per employee is $1.1 m.
Who are AbbVie competitors?
Competitors of AbbVie include Gilead Sciences, Immunomedics and Sanofi.
Where is AbbVie headquarters?
AbbVie headquarters is located at 1 Waukegan Rd, Lake Bluff.
Where are AbbVie offices?
AbbVie has offices in Lake Bluff, Cambridge, Mettawa, North Chicago and in 60 other locations.
How many offices does AbbVie have?
AbbVie has 67 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies